BfArM makes information on reported supply shortages available to the public. This information comes directly from the pharmaceutical entrepreneur and is supplemented by data from the Medicinal Product and Application Database (AmAnDa).

This database is updated automatically on the basis of the information reported. As a rule, the BfArM will have no further information on the supply status of the medicinal products listed.

The information supplied is within the sole responsibility of the respective marketing authorisation holders. Should you have further inquiries concerning reported supply bottlenecks, we therefore recommended that you contact the pharmaceutical entrepreneur directly at the telephone number or e-mail address provided for contact.